Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Visipaque in Coronary CT Angiography
NCT00335335Phase 3Terminated
- Sponsor
- GE HealthCare
- Start
- May 2006
- Primary completion
- Dec 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of iodixanol in coronary artery disease (CAD), sponsored by GE HealthCare. Started May 2006; status: terminated.
02
Drugs
iodixanol
03
Conditions
coronary artery disease (CAD)
Beyond the preview
Go deeper on NCT00335335.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00335335.